The UK National Institute for Health and Care Excellence (NICE) has granted approval for Roche’s breast cancer drug Kadcyla for routine use within the NHS region. NICE has recommended Kadcyla
Tag "UK"
The UK has the strongest and most robust clinical pipeline in Europe, with the number of drug products in development higher in the UK than anywhere else in the region,
The UK government says Merck Sharp & Dohme (MSD) broke competition laws by lowering the price of its Remicade drug as biosimilar rivals came to market. The Competition and Markets
Almost half of UK citizens say they or someone they know have experienced delays in care due to problems with disconnected patient data, according to new research by data
Ashfield Healthcare Communications, a global healthcare communications agency, announces significant growth across the UK and Europe. Ashfield Healthcare Communications has a new presence in Dublin, Ireland, joining the office of
Pfizer has announced it will provide its breast cancer drug, palbociclib — which has been provisionally rejected by NICE for routine use as a result of cost — to the
On April 18, 2017 Fujifilm announced the completion of a $93-million cGMP production facility in Texas. The facility expansion is part of the company’s goal to increase the production capacity
A new government report shows that digital health companies in the UK generated a turnover of over £1 billion in 2016. The annual report on medical technology and biopharmaceutical sectors
Now that the die has been cast, it’s time for the deal-making process to begin – if indeed a deal is on the cards. It seems that every time a
Score one for Samsung Bioepis in its quest to bring a biosimilar version of AbbVie’s anti-inflammatory behemoth Humira to market in Europe. This week, a U.K. court upturned two of the
In an editorial published in the journal ecancermedicalscience, leading academics from across the UK explore the risks facing cancer care, treatment and research in a post-Brexit world. The editorial is
The report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British
The University of Surrey has launched a new academic programme, aimed to help change the delivery of healthcare in the UK. Innovation for Health is an academic programme which combines
Over five million patients will soon be able to access Wi-Fi in early adopter GP practices as the NHS takes the first step towards rolling the service out across the
Healthcare communications specialists Fiona Edwards and Katie Langdon have launched a new creative agency specialising in pharmaceutical marketing services. Based in Reading, UK, Skin and Blister aims to ‘put the
Advertisements
